Agilon Health Insider Lowered Holding By 49% During Last Year
Agilon Health Insider Lowered Holding By 49% During Last Year
Insiders were net sellers of agilon health, inc.'s (NYSE:AGL ) stock during the past year. That is, insiders sold more stock than they bought.
內部人士是淨賣家安捷倫健康公司S(紐約證券交易所股票代碼:AGL)過去一年的股票。也就是說,內部人士賣出的股票多於他們買入的股票。
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
儘管我們不認為股東應該簡單地跟蹤內幕交易,但我們確實認為,密切關注內部人士的所作所為是完全合乎邏輯的。
Check out our latest analysis for agilon health
查看我們對Agilon Health的最新分析
The Last 12 Months Of Insider Transactions At agilon health
雅居倫健康公司最近12個月的內幕交易
The Chief Markets Officer, Ben Shaker, made the biggest insider sale in the last 12 months. That single transaction was for US$833k worth of shares at a price of US$23.81 each. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$18.75. So it is hard to draw any strong conclusion from it. The only individual insider seller over the last year was Ben Shaker.
首席市場官本·沙克在過去12個月中進行了最大規模的內幕交易。這一筆交易是以每股23.81美元的價格購買了價值83.3萬美元的股票。雖然我們通常不喜歡看到內幕出售,但如果以更低的價格出售,人們更擔心的是。令人欣慰的是,這次出售的價格遠遠高於目前18.75美元的股價。因此,很難從中得出任何強有力的結論。去年唯一的個人內幕賣家是本·謝克。
You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
你可以看到過去一年的內幕交易(由公司和個人),如下圖所示。如果你想知道到底是誰賣了,賣了多少錢,什麼時候賣的,只需點擊下面的圖表!
![insider-trading-volume](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20230919/0-d6c06345a125e5c6715a888fa8d940f6-0-20ed29c1c5c5a42df2d3ea2b48bd0325.png/big)
I will like agilon health better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
如果我看到一些大的內部收購,我會更喜歡Agilon Health。在我們等待的時候,看看這個免費最近有大量內幕收購的成長型公司名單.
Insider Ownership
內部人持股
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. agilon health insiders own about US$80m worth of shares. That equates to 1.1% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
看看一家公司的內部人持股總數,可以幫助你瞭解他們是否與普通股股東很好地結合在一起。內部人持股比例較高往往會讓公司領導層更加關注股東利益。Agilon Health內部人士擁有價值約8000萬美元的股票。這相當於該公司1.1%的股份。雖然這是一個強大但並不突出的內部人持股水準,但這足以表明管理層和小股東之間的某種一致性。
So What Does This Data Suggest About agilon health Insiders?
那麼,這些數據對Agilon Health內部人士有什麼啟示呢?
The fact that there have been no agilon health insider transactions recently certainly doesn't bother us. Still, the insider transactions at agilon health in the last 12 months are not very heartening. But it's good to see that insiders own shares in the company. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
最近沒有發生雅居倫健康內幕交易,這一事實當然不會讓我們感到困擾。儘管如此,雅居倫健康過去12個月的內幕交易並不是很令人振奮。但看到內部人士持有該公司的股份是件好事。如果你像我一樣,你可能會想一想這家公司是會增長還是會萎縮。幸運的是,你可以檢查這個免費顯示分析師對其未來預測的報告。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
如果你更願意看看另一家公司--一家財務狀況可能更好的公司--那麼不要錯過這一點免費列出了一些有趣的公司,這些公司擁有高股本回報率和低債務。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前只處理公開市場交易和私下處置直接權益,而不處理衍生工具交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.